Better Choice Announces SRx Health’s Participation at the 2025 Bloom Burton & Co. Healthcare Investor Conference on May 5th and 6th
Better Choice Company (NYSE: BTTR), a pet health and wellness company, has announced its participation in the upcoming 2025 Bloom Burton & Co. Healthcare Investor Conference. The event will take place at the Metro Toronto Convention Centre in Toronto, Ontario on May 5-6, 2025.
The company's management team from SRx Health will deliver their presentation on Tuesday, May 6, 2025, at 3:30 p.m. ET. Investors can access the presentation through the company's investor relations website. Additionally, management will be available for one-on-one meetings throughout the conference, which can be arranged through Bloom Burton & Co. representatives or by contacting KCSA directly.
Better Choice Company (NYSE: BTTR), un'azienda specializzata nella salute e nel benessere degli animali domestici, ha annunciato la sua partecipazione alla prossima 2025 Bloom Burton & Co. Healthcare Investor Conference. L'evento si svolgerà presso il Metro Toronto Convention Centre a Toronto, Ontario, il 5 e 6 maggio 2025.
Il team di gestione dell'azienda di SRx Health presenterà il proprio intervento martedì 6 maggio 2025, alle 15:30 ET. Gli investitori possono accedere alla presentazione tramite il sito web delle relazioni con gli investitori dell'azienda. Inoltre, la direzione sarà disponibile per incontri individuali durante tutto il convegno, che possono essere organizzati tramite i rappresentanti di Bloom Burton & Co. o contattando direttamente KCSA.
Better Choice Company (NYSE: BTTR), una empresa de salud y bienestar para mascotas, ha anunciado su participación en la próxima 2025 Bloom Burton & Co. Healthcare Investor Conference. El evento se llevará a cabo en el Metro Toronto Convention Centre en Toronto, Ontario, del 5 al 6 de mayo de 2025.
El equipo de gestión de la empresa de SRx Health realizará su presentación el martes 6 de mayo de 2025, a las 3:30 p.m. ET. Los inversores pueden acceder a la presentación a través del sitio web de relaciones con inversores de la empresa. Además, la dirección estará disponible para reuniones individuales durante toda la conferencia, que se pueden organizar a través de los representantes de Bloom Burton & Co. o contactando directamente a KCSA.
Better Choice Company (NYSE: BTTR), 애완동물 건강 및 웰빙 회사,가 다가오는 2025 Bloom Burton & Co. Healthcare Investor Conference에 참여한다고 발표했습니다. 이 행사는 2025년 5월 5일부터 6일까지 온타리오주 토론토의 메트로 토론토 컨벤션 센터에서 열릴 예정입니다.
SRx Health의 경영진이 2025년 5월 6일 화요일 오후 3:30 ET에 발표를 진행할 것입니다. 투자자들은 회사의 투자자 관계 웹사이트를 통해 발표에 접근할 수 있습니다. 또한, 경영진은 컨퍼런스 기간 동안 일대일 미팅을 위해 참석할 예정이며, 이는 Bloom Burton & Co.의 대표를 통해 또는 KCSA에 직접 연락하여 조정할 수 있습니다.
Better Choice Company (NYSE: BTTR), une entreprise spécialisée dans la santé et le bien-être des animaux de compagnie, a annoncé sa participation à la prochaine 2025 Bloom Burton & Co. Healthcare Investor Conference. L'événement se déroulera au Metro Toronto Convention Centre à Toronto, Ontario, les 5 et 6 mai 2025.
L'équipe de direction de SRx Health présentera sa présentation le mardi 6 mai 2025, à 15h30 ET. Les investisseurs peuvent accéder à la présentation via le site web des relations avec les investisseurs de l'entreprise. De plus, la direction sera disponible pour des réunions individuelles tout au long de la conférence, qui peuvent être organisées par l'intermédiaire des représentants de Bloom Burton & Co. ou en contactant directement KCSA.
Better Choice Company (NYSE: BTTR), ein Unternehmen für die Gesundheit und das Wohlbefinden von Haustieren, hat seine Teilnahme an der bevorstehenden 2025 Bloom Burton & Co. Healthcare Investor Conference bekannt gegeben. Die Veranstaltung findet am 5. und 6. Mai 2025 im Metro Toronto Convention Centre in Toronto, Ontario, statt.
Das Management-Team von SRx Health wird seine Präsentation am Dienstag, den 6. Mai 2025, um 15:30 Uhr ET halten. Investoren können die Präsentation über die Investor-Relations-Website des Unternehmens abrufen. Darüber hinaus wird das Management während der gesamten Konferenz für Einzelgespräche zur Verfügung stehen, die über die Vertreter von Bloom Burton & Co. oder direkt über KCSA arrangiert werden können.
- None.
- None.
TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that SRx Health’s management team will be presenting at the 2025 Bloom Burton & Co. Healthcare Investor Conference at the Metro Toronto Convention Centre, Toronto, Ontario on May 5-6, 2025.
2025 Bloom Burton & Co. Healthcare Investor Conference:
Presentation Date: Tuesday, May 6, 2025
Presentation Time: 3:30 p.m. ET
Webcast: https://ir.betterchoicecompany.com/news-events/events-presentations
Management will be available for 1x1 meetings throughout the conference. If you are interested, please contact your Bloom Burton & Co representative or email KCSA directly at BetterChoice@KCSA.com.
About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs and cats live healthier, happier and longer lives. We take an alternative, nutrition-based approach to pet health relative to conventional dog and cat food offerings and position our portfolio of brands to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. We have a demonstrated, multi-decade track record of success selling trusted pet health and wellness products and leverage our established digital footprint to provide pet parents with the knowledge to make informed decisions about their pet’s health. We sell the majority of our dog food, cat food and treats under the Halo brand, which is focused, respectively, on providing sustainably sourced kibble and canned food derived from real whole meat, and minimally processed raw-diet dog food and treats.
For more information, please visit https://www.betterchoicecompany.com.
About SRX Health
SRx operates as a Canadian healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. Distinguishing itself as a National Specialty Pharmacy provider, SRx concentrates on overseeing a patient's healthcare journey, spanning from acute pharmaceutical needs to chronic and rare disease management. This unique focus positions SRx to deliver a more holistic and integrated solution, catering to the requirements of both patients and key healthcare stakeholders. Our all-encompassing end-to-end offerings include wholesale/distribution facilities, patient support programs, infusion clinics, retail pharmacies, co-designed clinical programs, clinical trials, and diagnostic services.
Our strategic growth plan is forward-thinking and revolves around fostering increased collaboration with pharmaceutical manufacturers and prescribers. With a specific emphasis on the expanding market of chronic and rare diseases, we target specialty drugs associated with closed and limited distribution networks. The objective is to broaden their distribution and improve accessibility. Our overarching goal is to elevate our current presence from 34 to 100 specialty pharmacy locations across mid-sized population centers throughout Canada, thereby enhancing the scope of healthcare services and establishing new industry benchmarks. In the subsequent phase of SRx's evolution, we aim to extend our reach beyond the borders of Canada. Leveraging our comprehensive approach, we aspire to simplify healthcare on a global scale. For more information on SRx, please visit https://www.srxhealth.ca .
Company Contact:
Better Choice Company, Inc.
Kent Cunningham, CEO
Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com
